Phase 2 Study to Evaluate RPT193 in Adults With Moderate to Severe T2-high Asthma
Clinical trial NCT05935332 · TERMINATED
Trial details
- NCT number
- NCT05935332
- Sponsor
- RAPT Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-05
- Primary completion
- 2024-06-21
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.